BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18159774)

  • 21. Transitioning illicit drug preferences and emerging user identities in Ohio: The proliferation of methamphetamine use among African Americans.
    Flynn KC; Hoffer LD
    J Ethn Subst Abuse; 2019; 18(1):67-88. PubMed ID: 28678637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Callaghan RC; Cunningham JK; Sajeev G; Kish SJ
    Mov Disord; 2010 Oct; 25(14):2333-9. PubMed ID: 20737543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand users.
    Sheridan J; Butler R; Wheeler A
    J Psychoactive Drugs; 2009 Mar; 41(1):11-7. PubMed ID: 19455905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.
    Callaghan RC; Cunningham JK; Verdichevski M; Sykes J; Jaffer SR; Kish SJ
    Drug Alcohol Depend; 2012 Oct; 125(3):290-4. PubMed ID: 22503689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China.
    Liao M; Kang D; Tao X; Li J; Qian Y; Wang G; Jiang B; Bi Z; Jia Y
    AIDS Care; 2013; 25(10):1236-44. PubMed ID: 23394142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injection drug users, crack-cocaine users, and human services utilization: an exploratory study.
    Ashery RS; Carlson RG; Falck RS; Siegal HA
    Soc Work; 1995 Jan; 40(1):75-82. PubMed ID: 7863375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
    Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
    Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants.
    Cucciare MA; Ounpraseuth ST; Curran GM; Booth BM
    Subst Abus; 2019; 40(3):363-370. PubMed ID: 30810499
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009.
    Wilkins C; Sweetsur P; Griffiths R
    Drug Alcohol Rev; 2011 May; 30(3):255-63. PubMed ID: 21545555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical health, illicit drug use, and demographic characteristics in rural stimulant users.
    Garrity TF; Leukefeld CG; Carlson RG; Falck RS; Wang J; Booth BM
    J Rural Health; 2007; 23(2):99-107. PubMed ID: 17397365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of rural methamphetamine and cocaine users: results from a multistate community study.
    Booth BM; Leukefeld C; Falck R; Wang J; Carlson R
    J Stud Alcohol; 2006 Jul; 67(4):493-501. PubMed ID: 16736068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic affects of methamphetamine use.
    Hauer P
    S D Med; 2010 Aug; 63(8):285-7. PubMed ID: 20737995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crack cocaine trajectories among users in a midwestern American city.
    Falck RS; Wang J; Carlson RG
    Addiction; 2007 Sep; 102(9):1421-31. PubMed ID: 17645426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 39. A qualitative study of methamphetamine initiation among Chinese male users: Patterns and policy implications.
    Liu L; Chui WH; Chai X
    Int J Drug Policy; 2018 Dec; 62():37-42. PubMed ID: 30359871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.